Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights

Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline, andAcquisition of rights as licensor and manufacturer of Staccato® alprazolam...

Read more
Page 76 of 2181 1 75 76 77 2,181

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.